Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Pandemic fears: real and imagined

“Pandemic”. Few words in the English language conjure as much fear. The mere utterance evokes images of dying patients, surgical masks, haz-mat suits, a parade of coffins, helpless doctors and nurses, as the contagion spreads, first striking down the el...

U.S. Treasury Removes China as Currency Manipulator

The U.S. has formally removed China as a currency manipulator, just ahead of the signing of the ‘Phase 1’ deal. Given its past record, will China really change its ways? Kenny Fisher There was another positive develop...

Overlooked commodity of which China can't get enough

"Virtually every lumber customer we have in the state of Oregon is now cutting for the Chinese market." That quote comes straight from Rick Holley, CEO of Plum Creek Timber ( NYSE: PCL ), the biggest timberland owner in the U.S. The benchmark commodit...

Ucore Rare Metals Looks to Shift the Focus From China to the US for REE Supply

Ucore Rare Metals Inc. (TSXV:UCU) is grabbing the mining industry by the horns thanks to its critical minerals separation technology and developing rare earth elements (REE) separation facility in Alaska.

Aravive Shares Rise on Positive Patient Data from Phase 1b Ovarian Cancer Study

Shares of Aravive Inc. are trading higher after the firm posted positive data from the initial 12 patients enrolled in the Phase 1b portion of its study of AVB-500 used in the treatment of ovarian cancer. Today, in a late-breaking oral presentation at the European Soc...

The True Causes Behind the Yield Curve Inversion and Gold

By now, everyone and their brother has heard about the yield curve inversion. How come it has inverted and how much should we read into it? Is it really such a reliable indicator of an upcoming recession? Let’s dig into the true causes behind the inversion and ...

Iovance Biotherapeutics Shares Rise 12% on Updated Phase 2 Melanoma Study Results

Shares of Iovance Biotherapeutics traded 12% higher today after the firm reported updated clinical data from its phase 2 lifileucel metastatic melanoma trial. Just a few days after reporting third quarter 2019 earnings, late-stage biotechnology company Iovance Biothe...

Chimerix Shares Rise 50% as FDA Gives 'Go Ahead' for Phase 2/3 ALI Study in COVID-19 Patients

Shares of Chimerix Inc. traded higher after the company reported it has received U.S. FDA clearance to initiate a Phase 2/3 Study of dociparstat sodium in acute lung injury for patients afflicted with severe COVID-19. Biopharmaceutical company Chimerix Inc....

After China Trade Deal, Trump Takes Aim at Europe

The Trump administration has taken a tough stance in international trade negotiations. With the US-China deal sealed and Congress set to vote on the US-Mexico-Canada accord, will the European Union be President Trump’s next target? Kenny Fisher ...

This China sector is ramping up

Share | "Are you sure this is one of the top hospitals in Beijing? The paint's peeling!" This was my reaction after spending five minutes in a Chinese hospital. I asked our associate to do his best to snap some pictures without anyone noticing. (When your...
1 2 3 4 5 6 7 8 9 10 ...